Abstract
Pulmonary vaccine delivery has gained increasing attention during the last decade. This vaccination method has advantages other than parenteral vaccination such as it omits the application of needle. The appropriate formulation of antigens can result improved stability complications associated with conventional vaccines. Antigens formulated as nano carriers reach the respiratory airways of the lungs providing greater chance of uptake by relevant immune cells. These advances promise to accelerate the development and testing of new pulmonary vaccines against many human diseases. Keywords: Drug delivery, pulmonary delivery, vaccines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
